Longitudinal analysis of the peripheral B cell repertoire reveals unique effects of immunization with a new influenza virus strain

Genome Medicine

Volumn 7, Issue 1, 2015, Pages

  Cortina Ceballos, Bernardo ^a   Godoy Lozano, Elizabeth Ernestina ^a   Téllez Sosa, Juan ^a   Ovilla Muñoz, Marbella ^a   Sámano Sánchez, Hugo ^a   Aguilar Salgado, Andrés ^a   Gómez Barreto, Rosa Elena ^a   Valdovinos Torres, Humberto ^a   López Martínez, Irma ^b   Aparicio Antonio, Rodrigo ^b   Rodríguez, Mario H ^a   Martínez Barnetche, Jesús ^a  

^a INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^b Instituto Nacional de Diagnostico y Referencia Epidemiologicos   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

INACTIVATED VACCINE; INFLUENZA VACCINE; MONOVALENT INACTIVATED VACCINE; TRIPLE VACCINE; UNCLASSIFIED DRUG; VIRUS RNA; EPITOPE; IMMUNOGLOBULIN HEAVY CHAIN; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; RNA; VIRUS ANTIBODY;

2009 H1N1 INFLUENZA; AMPLICON; ARTICLE; B LYMPHOCYTE; BLOOD SAMPLING; CELL SELECTION; CONTROLLED STUDY; HEMAGGLUTINATION; IGVH GENE; INFLUENZA A VIRUS (H1N1); LONGITUDINAL STUDY; LYMPHOCYTE FUNCTION; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; SEQUENCE ANALYSIS; VACCINATION; VIRUS GENE; VIRUS IDENTIFICATION; VIRUS STRAIN; ADULT; BIOSYNTHESIS; BLOOD; DNA SEQUENCE; DRUG EFFECTS; GENETICS; HUMAN; IMMUNOLOGY; INFLUENZA, HUMAN; SOMATIC HYPERMUTATION;

ADULT; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; B-LYMPHOCYTES; EPITOPES, B-LYMPHOCYTE; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; LONGITUDINAL STUDIES; RNA; SEQUENCE ANALYSIS, DNA; SOMATIC HYPERMUTATION, IMMUNOGLOBULIN; VACCINES, INACTIVATED;

EID: 84955654242     PISSN: None     EISSN: 1756994X     Source Type: Journal    
DOI: 10.1186/s13073-015-0239-y     Document Type: Article

References (55)

1. WHO. Seasonal Flu: Fact sheet No. 211 OMS. Available at: http://www.who.int/mediacentre/factsheets/fs211/en/. Accessed 18 November 2015.
2. CDC. Estimates of deaths associated with Seasonal Influenza-United States, 1976-2007. Morb Mortal Wkly Rep. 2010;59(33):1057-62.
3. Skehel JJ, Wiley DC. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem. 2000;69:531-69.
4. Dougan SK, Ashour J, Karssemeijer RA, Popp MW, Avalos AM, Barisa M, et al. Antigen-specific B-cell receptor sensitizes B cells to infection by influenza virus. Nature. 2013;503(7476):406-9.
5. Subbarao K, Joseph T. Scientific barriers to developing vaccines against avian influenza viruses. Nat Rev Immunol. 2007;7(4):267-78.
6. Tong S, Zhu X, Li Y, Shi M, Zhang J, Bourgeois M, et al. New world bats harbor diverse influenza A viruses. PLoS Pathog. 2013;9(10):e1003657.
7. Okuno Y, Isegawa Y, Sasao F, Ueda S. A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains. J Virol. 1993;67(5):2552-8.
8. Throsby M, van den Brink E, Jongeneelen M, Poon LL, Alard P, Cornelissen L, et al. Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells. PLoS One. 2008;3(12):e3942.
9. Sui J, Hwang WC, Perez S, Wei G, Aird D, Chen LM, et al. Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat Struct Mol Biol. 2009;16(3):265-73.
10. Corti D, Suguitan AL, Pinna D, Silacci C, Fernandez-Rodriguez BM, Vanzetta F, et al. Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine. J Clin Invest. 2010;120(5):1663-73.
11. Crowe Jr JE. Influenza virus resistance to human neutralizing antibodies. mBio. 2012;3(4):e00213-12.
12. Zuccotti GV, Fabiano V. Strategies for preventing influenza: future perspectives in influenza vaccine technology. Expert Opin Biol Ther. 2011;11(1):1-4.
13. Robertson JS, Inglis SC. Prospects for controlling future pandemics of influenza. Virus Res. 2011;162:39-46.
14. Rappuoli R. The challenge of developing universal vaccines. F1000 medicine reports. 2011;3:16.
15. Boudinot P, Marriotti-Ferrandiz ME, Pasquier LD, Benmansour A, Cazenave PA, Six A. New perspectives for large-scale repertoire analysis of immune receptors. Mol Immunol. 2008;45(9):2437-45.
16. Rajewsky K, Forster I, Cumano A. Evolutionary and somatic selection of the antibody repertoire in the mouse. Science. 1987;238(4830):1088-94.
17. Davis MM. Bjorkman. Pamela J T-cell antigen receptor genes and T-cell recognition Nature. 1988;334:7.
18. Lingwood D, McTamney PM, Yassine HM, Whittle JR, Guo X, Boyington JC, et al. Structural and genetic basis for development of broadly neutralizing influenza antibodies. Nature. 2012;489:566-70.
19. Sasaki S, Jaimes MC, Holmes TH, Dekker CL, Mahmood K, Kemble GW, et al. Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines. J Virol. 2007;81(1):215-28.
20. Dormitzer PR, Galli G, Castellino F, Golding H, Khurana S, Del Giudice G, et al. Influenza vaccine immunology. Immunol Rev. 2011;239(1):167-77.
21. Xu R, Ekiert DC, Krause JC, Hai R, Crowe Jr JE, Wilson IA. Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus. Science. 2010;328(5976):357-60.
22. Krause JC, Tumpey TM, Huffman CJ, McGraw PA, Pearce MB, Tsibane T, et al. Naturally occurring human monoclonal antibodies neutralize both 1918 and 2009 pandemic influenza A (H1N1) viruses. J Virol. 2010;84(6):3127-30.
23. Wrammert J, Koutsonanos D, Li GM, Edupuganti S, Sui J, Morrissey M, et al. Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J Exp Med. 2011;208(1):181-93.
24. Thomson CA, Wang Y, Jackson LM, Olson M, Wang W, Liavonchanka A, et al. Pandemic H1N1 influenza infection and vaccination in humans induces cross-protective antibodies that target the hemagglutinin stem. Front Immunol. 2012;3:87.
25. Wrammert J, Smith K, Miller J, Langley WA, Kokko K, Larsen C, et al. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature. 2008;453(7195):667-71.
26. D'Angelo S, Glanville J, Ferrara F, Naranjo L, Gleasner CD, Shen X, et al. The antibody mining toolbox: an open source tool for the rapid analysis of antibody repertoires. MAbs. 2014;6(1):160-72.
27. Michaeli M, Barak M, Hazanov L, Noga H, Mehr R. Automated analysis of immunoglobulin genes from high-throughput sequencing: life without a template. J Clin Bioinformatics. 2013;3(1):15.
28. Mamedov IZ, Britanova OV, Zvyagin IV, Turchaninova MA, Bolotin DA, Putintseva EV, et al. Preparing unbiased T-cell receptor and antibody cDNA libraries for the deep next generation sequencing profiling. Front Immunol. 2013;4:456.
29. Matz M, Shagin D, Bogdanova E, Britanova O, Lukyanov S, Diatchenko L, et al. Amplification of cDNA ends based on template-switching effect and step-out PCR. Nucleic Acids Res. 1999;27(6):3.
30. Cortina-Ceballos B, Godoy-Lozano EE, Samano-Sanchez H, Aguilar-Salgado A, Velasco-Herrera MD, Vargas-Chavez C, et al. Reconstructing and mining the B cell repertoire with ImmunediveRsity. MAbs. 2015;7(3):516-240.
31. Finn RD, Clements J, Eddy SR. HMMER web server: interactive sequence similarity searching. Nucleic Acids Res (Web Server issue). 2011;39:W29-37.
32. Edgar RC. Search and clustering orders of magnitude faster than BLAST. Bioinformatics. 2010;25(19):2460-1.
33. Li S, Lefranc MP, Miles JJ, Alamyar E, Giudicelli V, Duroux P, et al. IMGT/HighV QUEST paradigm for T cell receptor IMGT clonotype diversity and next generation repertoire immunoprofiling. Nat Commun. 2013;4:2333.
34. Simberloff D. Species turnover and equilibrium island biogeography. Science. 1976;5(194):6.
35. Jost L. Entropy and diversity. Oikos. 2006;113(2):363-75.
36. Zipunnikov V, Caffo B, Yousem DM, Davatzikos C, Schwartz BS, Crainiceanu C. Functional principal component model for high-dimensional brain imaging. NeuroImage. 2011;58(3):772-84.
37. FactoMineR: Multivariate exploratory data analysis and data mining with R. R package version. 1.27 https://cran.r-project.org/web/packages/FactoMineR/index.html. Accessed 18 November 2015.
38. Valdes-Aleman J, Tellez-Sosa J, Ovilla-Munoz M, Godoy-Lozano E, Velazquez-Ramirez D, Valdovinos-Torres H, et al. Hybridization-based antibody cDNA recovery for the production of recombinant antibodies identified by repertoire sequencing. MAbs. 2014;6(2):493-501.
39. Li GM, Chiu C, Wrammert J, McCausland M, Andrews SF, Zheng NY, et al. Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells. Proc Natl Acad Sci U S A. 2012;109(23):9047-52.
40. Kalinke U, Bucher EM, Ernst B, Oxenius A, Roost HP, Geley S, et al. The role of somatic mutation in the generation of the protective humoral immune response against vesicular stomatitis virus. Immunity. 1996;5(6):639-52.
41. Tian C, Luskin GK, Dischert KM, Higginbotham JN, Shepherd BE, Crowe Jr JE. Immunodominance of the VH1-46 antibody gene segment in the primary repertoire of human rotavirus-specific B cells is reduced in the memory compartment through somatic mutation of nondominant clones. J Immunol. 2008;180(5):3279-88.
42. Ekiert DC, Bhabha G, Elsliger MA, Friesen RH, Jongeneelen M, Throsby M, et al. Antibody recognition of a highly conserved influenza virus epitope. Science. 2009;324(5924):246-51.
43. Davenport FM, Hennessy AV, Francis Jr T. Epidemiologic and immunologic significance of age distribution of antibody to antigenic variants of influenza virus. J Exp Med. 1953;98(6):641-56.
44. Francis Jr T, Davenport FM, Hennessy AV. A serological recapitulation of human infection with different strains of influenza virus. Trans Assoc Am Phys. 1953;66:231-9.
45. Corti D, Voss J, Gamblin SJ, Codoni G, Macagno A, Jarrossay D, et al. A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science. 2011;333(6044):850-6.
46. Wu YC, Kipling D, Dunn-Walters DK. Age-related changes in human peripheral blood IGH repertoire following vaccination. Front Immunol. 2012;3:193.
47. Jiang N, He J, Weinstein JA, Penland L, Sasaki S, He XS, et al. Lineage structure of the human antibody repertoire in response to influenza vaccination. Sci Transl Med. 2013;5(171):171ra19.
48. Krause JC, Tsibane T, Tumpey TM, Huffman CJ, Briney BS, Smith SA, et al. Epitope-specific human influenza antibody repertoires diversify by B cell intraclonal sequence divergence and interclonal convergence. J Immunol. 2011;187(7):3704-11.
49. Jackson KJ, Liu Y, Roskin KM, Glanville J, Hoh RA, Seo K, et al. Human responses to influenza vaccination show seroconversion signatures and convergent antibody rearrangements. Cell Host Microbe. 2014;16(1):105-14.
50. Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, Sun H, et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med. 2009;361(20):1945-52.
51. Wang C, Liu Y, Xu LT, Jackson KJ, Roskin KM, Pham TD, et al. Effects of aging, cytomegalovirus infection, and EBV infection on human B cell repertoires. J Immunol. 2014;192(2):603-11.
52. Ekiert DC, Friesen RH, Bhabha G, Kwaks T, Jongeneelen M, Yu W, et al. A highly conserved neutralizing epitope on group 2 influenza A viruses. Science. 2011;333(6044):843-50.
53. Xu R, Krause JC, McBride R, Paulson JC, Crowe Jr JE, Wilson IA. A recurring motif for antibody recognition of the receptor-binding site of influenza hemagglutinin. Nat Struct Mol Biol. 2013;20(3):363-70.
54. Kalinke U, Krebber A, Krebber C, Bucher E, Pluckthun A, Zinkernagel RM, et al. Monovalent single-chain Fv fragments and bivalent miniantibodies bound to vesicular stomatitis virus protect against lethal infection. Eur J Immunol. 1996;26(12):2801-6.
55. Crooks GE, Hon G, Chandonia JM, Brenner SE. WebLogo: a sequence logo generator. Genome Res. 2004;14(6):1188-90.